Viewing nowOlmesartan Medoxomil 20mg Tablet
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Eun-Il Biopharm Co., Ltd.

MFDS item code 202002276 · Approved 2020.04.01 · Insurance code 073001220
Treatment of essential hypertension
Essential hypertension is a condition of elevated blood pressure occurring without any specific cause, and this medication is used to lower blood pressure, protecting the heart and blood vessels, and preventing complications.
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect in approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended to take the medicine at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this medicine to patients aged 65 years or older. No overall differences in the efficacy or safety of this medicine have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm to the fetus and newborn if administered to women in the second and third trimesters of pregnancy, thus it must be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to any components of this drug, women who are pregnant or breastfeeding, patients undergoing renal dialysis, those with severe liver dysfunction, patients with biliary obstruction, and those with certain genetic lactose intolerance disorders. In patients with low blood volume or sodium deficiency, low blood pressure may occur; therefore, conditions must be thoroughly assessed before administration, and appropriate measures should be taken if hypotension occurs. This drug may affect kidney function, so patients with impaired renal function should regularly undergo blood tests to monitor kidney status and potassium levels. There is a risk of hyperkalemia, so patients with heart disease or renal disease should regularly monitor potassium levels in the blood. Dizziness may occur due to the blood pressure lowering effect, so caution should be exercised when performing hazardous tasks such as working at heights or driving. During the use of this medication, drug interactions may occur if combined with other antihypertensives, potassium-sparing diuretics, potassium supplements, lithium, non-steroidal anti-inflammatory drugs, etc., thus it is essential to consult with healthcare professionals. If gastrointestinal symptoms such as chronic diarrhea or weight loss occur, discontinue use of this medication and consult a physician, and if symptoms of intestinal vascular edema are observed, treatment should be discontinued immediately and further observation is required. Pregnant or breastfeeding women should consult with a physician before taking this medication, and if breastfeeding, consideration should be given to discontinuing the medication or breastfeeding during treatment. Safety in children has not been fully established, so it should be administered with caution in pediatric patients. In case of overdose, symptoms such as hypotension or palpitations may occur; therefore, it is crucial to adhere to the prescribed dosage and notify healthcare providers immediately if any adverse symptoms arise.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain the storage temperature in the range of 1 to 25 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer time.
White, round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Eun-Il Biopharm Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.